David M. Berman
Impact in
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Immunology top 0.5%
- Immunotherapy and Immune Responses
Papers in
-
- Epigenetics and DNA Methylation 18
- Oncology 61
- Cancer Immunotherapy and Biomarkers 26
- CAR-T cell therapy research 15
- Co-authors
- Alfred G. Gilman (6 shared papers)Philip A. Beachy (8 shared papers)Sunil Karhadkar (7 shared papers)D. Neil Watkins (7 shared papers)Omid Hamid (13 shared papers)Jeffrey S. Weber (11 shared papers)Thomas M. Wilkie (2 shared papers)Stephen B. Baylin (3 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Cancer Research (11 papers)Wildlife Research (10 papers)Blood (6 papers)The Prostate (6 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
David M. Berman
253 papers receiving 19.4k citations
David M. Berman's Hit Papers
Peers
Comparison fields: 5 of 182
- Oncology 6.7k
- Immunology 3.1k
- Molecular Biology 10.2k
- Cancer Research 1.5k
- Pulmonary and Respiratory Medicine 2.4k
Countries citing papers authored by David M. Berman
This map shows the geographic impact of David M. Berman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Berman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Berman more than expected).
Fields of papers citing papers by David M. Berman
This network shows the impact of papers produced by David M. Berman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Berman. The network helps show where David M. Berman may publish in the future.
Co-authors
The 25 scholars most cited alongside David M. Berman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 263 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma Hit paper breakdown → | 2015 | 1571 |
| 2 | Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours Hit paper breakdown → | 2003 | 1022 |
| 3 | Tissue repair and stem cell renewal in carcinogenesis Hit paper breakdown → | 2004 | 909 |
| 4 | Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer Hit paper breakdown → | 2003 | 878 |
| 5 | A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing Hit paper breakdown → | 2007 | 808 |
| 6 | Hedgehog signalling in prostate regeneration, neoplasia and metastasis Hit paper breakdown → | 2004 | 785 |
| 7 | Structure of RGS4 Bound to AlF4−-Activated Giα1: Stabilization of the Transition State for GTP Hydrolysis Hit paper breakdown → | 1997 | 682 |
| 8 | GAIP and RGS4 Are GTPase-Activating Proteins for the Gi Subfamily of G Protein α Subunits Hit paper breakdown → | 1996 | 659 |
| 9 | Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade Hit paper breakdown → | 2002 | 633 |
| 10 | An immune-active tumor microenvironment favors clinical response to ipilimumab Hit paper breakdown → | 2011 | 601 |
| 11 | Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism Hit paper breakdown → | 1991 | 525 |
| 12 | Evolving synergistic combinations of targeted immunotherapies to combat cancer Hit paper breakdown → | 2015 | 506 |
| 13 | 2009 | 462 | |
| 14 | 2011 | 444 | |
| 15 | Clinical implications of PTEN loss in prostate cancer Hit paper breakdown → | 2018 | 441 |
| 16 | 1998 | 418 | |
| 17 | 2005 | 365 | |
| 18 | 2010 | 336 | |
| 19 | 1997 | 331 | |
| 20 | 1996 | 300 |
About David M. Berman
David M. Berman is a scholar working on Molecular Biology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Epidemiology, having authored 263 papers that have together received 19.9k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (36 papers), Cancer Immunotherapy and Biomarkers (26 papers), Prostate Cancer Treatment and Research (23 papers), Epigenetics and DNA Methylation (18 papers), CAR-T cell therapy research (15 papers), Immunotherapy and Immune Responses (14 papers), Urinary and Genital Oncology Studies (14 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). The work is most often cited by research in Oncology (6.7k citations), Immunology (3.1k citations), Molecular Biology (10.2k citations), Cancer Research (1.5k citations) and Pulmonary and Respiratory Medicine (2.4k citations). David M. Berman has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Alfred G. Gilman, Philip A. Beachy, Sunil Karhadkar, D. Neil Watkins, Omid Hamid, Jeffrey S. Weber, Thomas M. Wilkie, Stephen B. Baylin, David W. Russell and Anirban Maitra. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Wildlife Research, Blood and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.